Beam Therapeutics

Last updated: January 20, 2024

CEO John Evans and cofounders, David Liu, Keith Joung, and Feng Zhang

Country: USA | Funding: $689M (+)

Website: https://beamtx.com/

Beam Therapeutics develops of genome editing technologies.